Pernix Therapeutics Holdings (PTX) Q2 2014 Results - Earnings Call Webcast

 |  About: Pernix Therapeutics Holdings, Inc. (PTX)
by: SA Transcripts

Pernix Therapeutics (NASDAQ:PTX): Q2 GAAP EPS of -$0.16. Revenue of $17.38M (-15.5% Y/Y) misses by $8.82M.

The following audio is from a conference call that will begin on August 11, 2014 at 10:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.